Results 151 to 160 of about 462,808 (314)

Morbihan Disease May Induce Nonspecific Inflammatory of Extra-Facial Region: A Case Report and Literature Review

open access: yesClinical, Cosmetic and Investigational Dermatology
FeiFang Deng,1,2 Peng Wang2 1Women and Children’s Health Care Hospital of Luohu, Shenzhen, People’s Republic of China; 2Department of Dermatology, Affiliated Nanshan Hospital of Shenzhen University (Shenzhen Nanshan People’s Hospital), Shenzhen ...
Deng F, Wang P
doaj  

The impact of a preprescribing formative assessment on learning in final‐year medical students using hospital inpatient electronic prescribing systems

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Graduating medical students consistently report being unprepared for the complexity of prescribing in clinical practice. Current clinical prescribing teaching and authentic assessment are limited due to patient safety concerns. We aimed to examine the educational utility of supervised preprescribing as a learning process and potential authentic ...
Kellie A. Charles   +7 more
wiley   +1 more source

Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control

open access: yesClinical, Cosmetic and Investigational Dermatology
Maoying Li,1 Xi Wang,2 Jiehui Chen,2 Tao Deng,2 Cuihong Lian3 1Department of Dermatology and Venereology,Guanxi University of Chinese Medicine, Nanning, 530000, People’s Republic of China; 2Department of Dermatology and Venereology,The First Clinical ...
Li M, Wang X, Chen J, Deng T, Lian C
doaj  

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

A Prospective, Multicenter, Randomized, Assessor-Blinded Study Assessing the Efficacy and Safety of Injectable Non-Cross-Linked Hyaluronic Acid for Improving Facial Skin Rejuvenation

open access: yesClinical, Cosmetic and Investigational Dermatology
Haiyan Cheng,1 Meng Jiang,1 Shan Zhong,1 Xinhai Liu,2 Dongsheng Cao,3 Qiuyuan Feng,4 Yongzhong Li,5 Wei Xu1 1Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Plastic ...
Cheng H   +7 more
doaj  

Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis). [PDF]

open access: yesActa Derm Venereol
Pezzolo E   +34 more
europepmc   +1 more source

DERMATOLOGY

open access: yesJournal of Occupational and Environmental Medicine, 1970
openaire   +1 more source

Dermatologic emergencies [PDF]

open access: yesCanadian Medical Association Journal, 2005
Anatoli, Freiman   +2 more
openaire   +2 more sources

Model‐informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Population pharmacokinetic (popPK) and pharmacokinetic‐pharmacodynamic (PK/PD) models were developed to support clinical development of nemolizumab, a humanized monoclonal antibody targeting the IL‐31 receptor α, in adolescents and adults with moderate‐to‐severe atopic dermatitis (AD).
Floris Fauchet   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy